1. Academic Validation
  2. Discovery of potent and selective small-molecule PAR-2 agonists

Discovery of potent and selective small-molecule PAR-2 agonists

  • J Med Chem. 2008 Sep 25;51(18):5490-3. doi: 10.1021/jm800754r.
Jimmi Gerner Seitzberg 1 Anne Eeg Knapp Birgitte Winther Lund Sine Mandrup Bertozzi Erika A Currier Jian-Nong Ma Vladimir Sherbukhin Ethan S Burstein Roger Olsson
Affiliations

Affiliation

  • 1 ACADIA Pharmaceuticals AB, Medeon Science Park, Per Albin Hanssons Väg 35, S-205 12 Malmö, Sweden.
Abstract

Proteinase activated receptor-2 plays a crucial role in a wide variety of conditions with a strong inflammatory component. We present the discovery and characterization of two structurally different, potent, selective, and metabolically stable small-molecule PAR-2 agonists. These ligands may be useful as pharmacological tools for elucidating the complex physiological role of the PAR-2 receptors as well as for the development of PAR-2 antagonists.

Figures
Products